All In Biotech

Drug Trial Radar · NCT03195673

Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting

A Pilot Study Assessing the Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting

Last checked: Nov 20, 2026Latest source record: Dec 11, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

160

Planned (sponsor's estimate)

Start

Mar 2, 2018

Primary completion

Nov 15, 2019

Study completion Dec 15, 2019

Sponsor

Lead sponsor
Capital Medical UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
The Luhe Teaching Hospital of the Capital Medical University; Beijing Anzhen Hospital
First posted
Jun 22, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the safety and efficacy of low dosage of Terazosin in Carotid Artery Stenting

Conditions

  • Carotid Artery Stenosis

Interventions

  • TerazosinDrug

    TZ 0.5mg once a day for 3-7 days before carotid artery stenting to 30 days later.

  • Carotid artery stentingProcedure

    Carotid artery stenting is an alternative treatment of carotid artery stenosis, which would be performed by experienced neuroradiologist according to the latest guideline from American Heart Association and American Stroke Association.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Participants who got New DWI Lesions (MRI)Time frame: Within 48 hours after carotid artery stenting

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Anzhen Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • The Luhe Teaching Hospital of the Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.